JPRN-jRCT2080222949未知2 期
A Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemia
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •[Main inclusion criteria]
- •1.With BMI >=25.0
- •2.With visceral fat area >=100 cm2
- •3.Patients who meets following criteria
- •A)Previously diagnosed with glucose intolerance or type 2 diabetes [HbA1c >=6.5% to <9.0% (NGSP)]
- •B)Previously diagnosed as hyperlipidemia with TG >=150 mg/dL and/or HDL-C <40 mg/dL and/or LDL-C >=140 mg/d
排除标准
- •[Main exclusion criteria]
- •1.Patients with symptomatic obesity
- •2.Patients with serious hepatic, renal, cardiovascular, respiratory, or hematological disorders
研究者
相似试验
未知
2 期
A Japanese early phase 2 study of S-444823 ointment in patients with atopic dermatitisAtopic DermatitisJPRN-jRCT2080220964SHIONOGI & CO., LTD.230
未知
1 期
A Phase 1 Study of LY2584702 in Japanese Patients with Solid TumorsCancerJPRN-jRCT2080221292Eli Lilly Japan K.K.
未知
2 期
Phase II Study of S-555739 in Patients with Japanese Cedar Pollinosis in an Environmental Challenge ChamberJPRN-jRCT2080221936SHIONOGI & CO., LTD.
未知
1 期
A Phase 1 Study of LY2606368 in Japanese Patients with Advanced Solid TumorseoplasmJPRN-jRCT2080222962Eli Lilly Japan K.K.
终止
2 期
A Clinical Phase 2 Study of E6011 in Japanese Subjects with Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic AcidPrimary Biliary CholangitisJPRN-jRCT2080223460EA Pharma Co.,Ltd.80